Vaxess Technologies today announced a rebranding to Terrestrial Bio, Inc., along with $50 million in Series C financing.

Affymetrix Inc. has announced the publication of the MicroArray Quality Control (MAQC) study, a collaborative effort led by the FDA that included 137 scientists from private and public sector ...

Thermo Fisher Scientific, Inc. TMO recently launched the Applied Biosystems CytoScan HD Accel array — a new chromosomal microarray intended to enhance cytogenetic research lab productivity, efficiency ...

Atlanta (June 16 2025)-- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray technology, is now ...

"[People] had been developing Arabidopsis microarrays for a number of years, and these were some of the first papers that published high-quality data with real biological conclusions," says Chris Town ...

Forbes contributors publish independent expert analyses and insights. Steven covers accessibility and assistive technologies. As somewhat of a self-described home theater nerd, I’ve long associated ...

Get our Editor-in-Chief Michelle Itano's BioTechniques Q1 2026 highlights, featuring an optimized Southern blot protocol and ...

Reported Data Supports the Potential Extension of HD-MAP Vaccine Delivery to Oncology Indications Recently published data generated by researchers at The University of Queensland and Vaxxas shows ...

The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...